EX-99.2 3 exhibit992q32022fs.htm EX-99.2 Document


image3.jpg
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

GILDAN ACTIVEWEAR INC.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(in thousands of U.S. dollars) - unaudited
October 2,
2022		January 2,
2022
Current assets:
Cash and cash equivalents$69,249 $179,246 
Trade accounts receivable (note 4)431,476 329,967 
Inventories (note 5)1,112,532 774,358 
Prepaid expenses, deposits and other current assets116,725 163,662 
Total current assets1,729,982 1,447,233 
Non-current assets:
Property, plant and equipment1,060,311 985,073 
Right-of-use assets77,499 92,447 
Intangible assets296,545 306,630 
Goodwill (note 8(f))269,923 283,815 
Deferred income taxes3,448 17,726 
Other non-current assets2,290 3,758 
Total non-current assets1,710,016 1,689,449 
Total assets$3,439,998 $3,136,682 
Current liabilities:
Accounts payable and accrued liabilities$503,032 $440,401 
Income taxes payable4,012 7,912 
Current portion of lease obligations (note 8(d))
13,442 15,290 
Current portion of long-term debt (note 6)150,000 — 
Total current liabilities670,486 463,603 
Non-current liabilities:
Long-term debt (note 6)770,000 600,000 
Lease obligations (note 8(d))
79,460 93,812 
Other non-current liabilities61,741 59,862 
Total non-current liabilities911,201 753,674 
Total liabilities1,581,687 1,217,277 
Equity:
Share capital186,229 191,732 
Contributed surplus76,693 58,128 
Retained earnings1,567,241 1,604,736 
Accumulated other comprehensive income (note 10)28,148 64,809 
Total equity attributable to shareholders of the Company1,858,311 1,919,405 
Total liabilities and equity$3,439,998 $3,136,682 
See accompanying notes to unaudited condensed interim consolidated financial statements.
QUARTERLY REPORT - Q3 2022 35


image3.jpg
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
GILDAN ACTIVEWEAR INC.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF EARNINGS
AND COMPREHENSIVE INCOME
(in thousands of U.S. dollars, except per share data) - unaudited
Three months endedNine months ended
October 2,
2022		October 3,
2021		October 2,
2022		October 3,
2021
Net sales (note 14)$850,008 $801,581 $2,520,460 $2,138,319 
Cost of sales (note 8(e))597,839 519,915 1,762,873 1,427,366 
Gross profit252,169 281,666 757,587 710,953 
Selling, general and administrative expenses79,409 80,645 248,302 233,705 
Impairment (Reversal of impairment) of trade accounts receivable (note 4)2,821 (1,280)4,368 (1,619)
Restructuring and acquisition-related (recovery) costs (note 7)(4,637)964 (5,837)4,044 
Operating income174,576 201,337 510,754 474,823 
Financial expenses, net (note 8(b))
9,311 5,316 23,675 22,666 
Earnings before income taxes 165,265 196,021 487,079 452,157 
Income tax expense12,229 7,717 29,439 18,870 
Net earnings153,036 188,304 457,640 433,287 
Other comprehensive (loss) income, net of related income taxes (note 10):
Cash flow hedges(40,441)42,078 (36,661)53,503 
Comprehensive income$112,595 $230,382 $420,979 $486,790 
Earnings per share (note 11):
Basic$0.84 $0.95 $2.47 $2.19 
Diluted$0.84 $0.95 $2.46 $2.18 
See accompanying notes to unaudited condensed interim consolidated financial statements.

QUARTERLY REPORT - Q3 2022 36


image3.jpg
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

GILDAN ACTIVEWEAR INC.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
Nine months ended October 2, 2022 and October 3, 2021
(in thousands or thousands of U.S. dollars) - unaudited
Share capitalContributed
surplus		Accumulated
other
comprehensive
income (loss)		Retained
earnings		Total
equity
NumberAmount
Balance, January 2, 2022192,267 $191,732 $58,128 $64,809 $1,604,736 $1,919,405 
Share-based compensation— — 23,974 — — 23,974 
Shares issued under employee share purchase plan
33 1,114 — — — 1,114 
Shares issued pursuant to exercise of stock options
43 1,343 (327)— — 1,016 
Shares issued or distributed pursuant to vesting of restricted share units
150 4,255 (8,319)— — (4,064)
Shares repurchased for cancellation(11,897)(12,099)— — (395,151)(407,250)
Share repurchases for settlement of non-Treasury RSUs
(148)(116)— — (5,593)(5,709)
Deferred compensation to be settled in non-Treasury RSUs— — 2,110 — — 2,110 
Dividends declared— — 1,127 — (94,391)(93,264)
Transactions with shareholders of the Company recognized directly in equity
(11,819)(5,503)18,565 — (495,135)(482,073)
Cash flow hedges (note 10)— — — (36,661)— (36,661)
Net earnings— — — — 457,640 457,640 
Comprehensive income— — — (36,661)457,640 420,979 
Balance, October 2, 2022180,448 $186,229 $76,693 $28,148 $1,567,241 $1,858,311 
Balance, January 3, 2021198,407 $183,938 $24,936 $(9,038)$1,359,061 $1,558,897 
Share-based compensation— — 29,087 — — 29,087 
Shares issued under employee share purchase plan
33 1,026 — — — 1,026 
Shares issued pursuant to exercise of stock options
83 2,727 (639)— — 2,088 
Shares issued or distributed pursuant to vesting of restricted share units
66 1,978 (3,549)— — (1,571)
Shares repurchased for cancellation
(3,314)(3,147)— — (123,850)(126,997)
Share repurchases for settlement of non-Treasury RSUs(65)(47)— — (1,710)(1,757)
Deferred compensation to be settled in non-Treasury RSUs— — 2,197 — — 2,197 
Dividends declared— — 640 — (61,388)(60,748)
Transactions with shareholders of the Company recognized directly in equity
(3,197)2,537 27,736 — (186,948)(156,675)
Cash flow hedges (note 10)— — — 53,503 — 53,503 
Net earnings— — — — 433,287 433,287 
Comprehensive income— — — 53,503 433,287 486,790 
Balance, October 3, 2021195,210 $186,475 $52,672 $44,465 $1,605,400 $1,889,012 
See accompanying notes to unaudited condensed interim consolidated financial statements.
QUARTERLY REPORT - Q3 2022 37


image3.jpg
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
GILDAN ACTIVEWEAR INC.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands of U.S. dollars) - unaudited
Three months endedNine months ended
October 2,
2022		October 3,
2021		October 2,
2022		October 3,
2021
Cash flows from (used in) operating activities:
Net earnings$153,036 $188,304 $457,640 $433,287 
Adjustments for:
Depreciation and amortization (note 8(a))31,145 34,259 96,889 105,753 
Non-cash restructuring (gains) costs related to property, plant and equipment, right-of-use assets, and computer software (note 7)(5,441)265 (8,175)448 
Timing differences between settlement of financial derivatives and transfer of deferred gains and losses in accumulated OCI to inventory and net earnings(29,732)2,851 7,941 (4,997)
Insurance recovery gain, net of loss on disposal of property, plant and equipment22 (28,008)(6,192)(48,324)
Share-based compensation8,358 12,708 24,079 29,184 
Other (note 12(a))12,841 5,568 16,951 3,724 
Changes in non-cash working capital balances (note 12(c))(104,386)26,629 (365,017)(55,585)
Cash flows from operating activities65,843 242,576 224,116 463,490 
Cash flows from (used in) investing activities:
Purchase of property, plant and equipment(73,597)(48,056)(160,042)(90,067)
Purchase of intangible assets(940)(579)(4,048)(1,750)
Business dispositions (acquisitions)27,880 — 27,880 — 
Proceeds from insurance related to property, plant and equipment (PP&E) and other disposals of PP&E1,373 38,180 6,672 106,358 
Cash flows (used in) from investing activities(45,284)(10,455)(129,538)14,541 
Cash flows from (used in) financing activities:
Increase (Decrease) in amounts drawn under long-term bank credit facility105,000 — 320,000 — 
Payment of term loan— — — (400,000)
Payment of lease obligations(4,028)(3,469)(13,149)(12,481)
Dividends paid(30,633)(30,445)(93,264)(60,748)
Proceeds from the issuance of shares318 313 2,025 3,017 
Repurchase and cancellation of shares(94,045)(119,715)(408,220)(119,715)
Share repurchases for settlement of non-Treasury RSUs— — (5,709)(1,757)
Withholding taxes paid pursuant to the settlement of non-Treasury RSUs
— — (4,064)(1,571)
Cash flows used in financing activities(23,388)(153,316)(202,381)(593,255)
Effect of exchange rate changes on cash and cash equivalents denominated in foreign currencies
(1,588)(328)(2,194)(708)
(Decrease) Increase in cash and cash equivalents during the period(4,417)78,477 (109,997)(115,932)
Cash and cash equivalents, beginning of period73,666 310,855 179,246 505,264 
Cash and cash equivalents, end of period$69,249 $389,332 $69,249 $389,332 
Cash paid during the period (included in cash flows from (used in) operating activities):
Interest$9,397 $5,858 $20,050 $19,344 
Income taxes, net of refunds4,081 1,136 19,687 2,979 
Supplemental disclosure of cash flow information (note 12).
See accompanying notes to unaudited condensed interim consolidated financial statements.
QUARTERLY REPORT - Q3 2022 38


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

For the period ended October 2, 2022
(Tabular amounts in thousands or thousands of U.S. dollars except per share data, unless otherwise indicated)

1. REPORTING ENTITY:
Gildan Activewear Inc. (the "Company" or "Gildan") is domiciled in Canada and is incorporated under the Canada Business Corporations Act. Its principal business activity is the manufacture and sale of activewear, hosiery, and underwear. The Company’s fiscal year ends on the Sunday closest to December 31 of each year.

The address of the Company’s registered office is 600 de Maisonneuve Boulevard West, Suite 3300, Montreal, Quebec. These unaudited condensed interim consolidated financial statements are as at and for the three and nine months ended October 2, 2022 and include the accounts of the Company and its subsidiaries. The Company is a publicly listed entity and its shares are traded on the Toronto Stock Exchange and New York Stock Exchange under the symbol GIL.

2. BASIS OF PREPARATION:
(a) Statement of compliance:
These unaudited condensed interim consolidated financial statements have been prepared in accordance with International Accounting Standard (“IAS”) 34, Interim Financial Reporting, as issued by the International Accounting Standards Board (“IASB”). These unaudited condensed interim consolidated financial statements should be read in conjunction with the Company’s fiscal 2021 audited consolidated financial statements. The Company applied the same accounting policies in the preparation of these unaudited condensed interim consolidated financial statements as those disclosed in note 3 of its most recent annual consolidated financial statements.

These unaudited condensed interim consolidated financial statements were authorized for issuance by the Board of Directors of the Company on November 2, 2022.

(b) Seasonality of the business:
The Company’s net sales are subject to seasonal variations. Net sales have historically been higher during the second and third quarters.

(c) Operating segments:
The Company manages its business on the basis of one reportable operating segment.
QUARTERLY REPORT - Q3 2022 39


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

3. NEW ACCOUNTING STANDARDS AND INTERPRETATIONS NOT YET APPLIED:
Amendments to IAS 1, Presentation of Financial Statements
On January 23, 2020, the IASB issued narrow-scope amendments to IAS 1, Presentation of Financial Statements, to clarify how to classify debt and other liabilities as current or non-current. The amendments (which affect only the presentation of liabilities in the statement of financial position) clarify that the classification of liabilities as current or non-current should be based on rights that are in existence at the end of the reporting period to defer settlement by at least twelve months and make explicit that only rights in place at the end of the reporting period should affect the classification of a liability; clarify that classification is unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability; and make clear that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets, or services. The amendments are effective for annual reporting periods beginning on or after January 1, 2023 and are to be applied retrospectively. Earlier application is permitted. These amendments are subject to future developments. Certain application issues resulting from the 2020 amendments were raised with the Board, which resulted in the Board publishing exposure draft ED/2021/9 Non-current Liabilities with Covenants in November 2021. Further amendments to IAS 1 are proposed as well as a deferral of the effective date of the 2020 amendments to no earlier than January 1, 2024. The exposure draft was open for comment until March 21, 2022. The Company is currently evaluating the impact of the amendment on its consolidated financial statements.

Amendments to IAS 1 and IFRS Practice Statement 2, Disclosure of Accounting Policy Information
In February 2021, the IASB issued amendments to IAS 1 Presentation of Financial Statements and IFRS Practice Statement 2 Making Materiality Judgements. The amendments help entities provide accounting policy disclosures that are more useful to primary users of financial statements by:

–Replacing the requirement to disclose “significant” accounting policies under IAS 1 with a requirement to disclose “material” accounting policies. Under this, an accounting policy would be material if, when considered together with other information included in an entity’s financial statements, it can reasonably be expected to influence decisions that primary users of general purpose financial statements make on the basis of those financial statements.
–Providing guidance in IFRS Practice Statement 2 to explain and demonstrate the application of the four-step materiality process to accounting policy disclosures.

The amendments shall be applied prospectively. The amendments to IAS 1 are effective for annual periods beginning on or after January 1, 2023. Earlier application is permitted. Once an entity applies the amendments to IAS 1, it is also permitted to apply the amendments to IFRS Practice Statement 2. The Company is currently evaluating the impact of the amendments on its consolidated financial statements.

Amendments to IAS 8, Definition of Accounting Estimates
In February 2021, the IASB amended IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors to introduce a new definition of “accounting estimates” to replace the definition of “change in accounting estimates” and also include clarifications intended to help entities distinguish changes in accounting policies from changes in accounting estimates. This distinction is important because changes in accounting policies must be applied retrospectively while changes in accounting estimates are accounted for prospectively. The amendments are effective for annual periods beginning on or after January 1, 2023. Earlier application is permitted. The Company is currently evaluating the impact of the amendment on its consolidated financial statements.

Amendments to IAS 12, Deferred Tax Related to Assets and Liabilities Arising from a Single Transaction
On May 7, 2021, the IASB amended IAS 12 Income Taxes, to narrow the scope of the initial recognition exemption so that it does not apply to transactions that give rise to equal and offsetting temporary differences. The amendments are effective for annual periods beginning on or after January 1, 2023. The Company is currently evaluating the impact of the amendment on its consolidated financial statements.

QUARTERLY REPORT - Q3 2022 40


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

4. TRADE ACCOUNTS RECEIVABLE:
October 2,
2022		January 2,
2022
Trade accounts receivable$449,526 $343,671 
Allowance for expected credit losses(18,050)(13,704)
$431,476 $329,967 

As at October 2, 2022, trade accounts receivables being serviced under a receivables purchase agreement amounted to $126.2 million (January 2, 2022 - $144.9 million). The receivables purchase agreement, which allows for the sale of a maximum of $225 million of accounts receivables at any one time, expires on June 19, 2023, subject to annual extensions. The Company retains servicing responsibilities, including collection, for these trade receivables but has not retained any credit risk with respect to any trade receivables that have been sold. The difference between the carrying amount of the receivables sold under the agreement and the cash received at the time of transfer was $1.4 million (2021 - $0.4 million) and $2.7 million (2021 - $1.2 million), respectively for the three and nine months ended October 2, 2022, and was recorded in bank and other financial charges.

The movement in the allowance for expected credit losses in respect of trade receivables was as follows:
Three months endedNine months ended
October 2,
2022		October 3,
2021		October 2,
2022		October 3,
2021
Allowance for expected credit losses, beginning of period$(15,317)$(18,495)$(13,704)$(18,994)
(Impairment) Reversal of impairment of trade accounts receivable(2,821)1,280 (4,368)1,619 
Write-off of trade accounts receivable88 5 22 165 
Allowance for expected credit losses, end of period$(18,050)$(17,210)$(18,050)$(17,210)


5. INVENTORIES:
October 2,
2022		January 2,
2022
Raw materials and spare parts inventories$235,371 $183,065 
Work in progress85,787 53,482 
Finished goods791,374 537,811 
$1,112,532 $774,358 


QUARTERLY REPORT - Q3 2022 41


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

6. LONG-TERM DEBT:
Effective interest rate(1)
Principal amountMaturity date
October 2,
2022		January 2,
2022
Non-current portion of long-term debt
Revolving long-term bank credit facility, interest at variable U.S. interest rate(2)(3)
2.5%$320,000 $— March 2027
Term loan, interest at variable U.S. interest rate, payable monthly(2)(4)
2.6%300,000 300,000 June 2026
Notes payable, interest at fixed rate of 2.70%, payable semi-annually(5)
n/a— 100,000 August 2023
Notes payable, interest at Adjusted LIBOR plus a spread of 1.53%, payable quarterly(5)
n/a— 50,000 August 2023
Notes payable, interest at fixed rate of 2.91%, payable semi-annually(5)
2.9%100,000 100,000 August 2026
Notes payable, interest at Adjusted LIBOR plus a spread of 1.57%, payable quarterly(5)
2.9%50,000 50,000 August 2026
$770,000 $600,000 
Current portion of long-term debt
Notes payable, interest at fixed rate of 2.70%, payable semi-annually(5)
2.7%$100,000 $— August 2023
Notes payable, interest at Adjusted LIBOR plus a spread of 1.53%, payable quarterly(5)
2.7%50,000 — August 2023
$150,000 $— 
(1)Represents the annualized effective interest rate for the nine months ended October 2, 2022, including the cash impact of interest rate swaps, where applicable.
(2)SOFR advances at adjusted Term SOFR (includes a 0% to 0.25% reference rate adjustment) plus a spread ranging from 1% to 3%.
(3)The Company’s committed unsecured revolving long-term bank credit facility of $1 billion provides for an annual extension which is subject to the approval of the lenders. The spread added to the adjusted Term SOFR is a function of the total net debt to EBITDA ratio (as defined in the credit facility agreement and its amendments). In addition, an amount of $43.7 million (January 2, 2022 - $51.1 million) has been committed against this facility to cover various letters of credit.
(4)The unsecured term loan is non-revolving and can be prepaid in whole or in part at any time with no penalties. The spread added to the adjusted Term SOFR is a function of the total net debt to EBITDA ratio (as defined in the term loan agreements and its amendments).
(5)The unsecured notes issued for a total aggregate principal amount of $300 million to accredited investors in the U.S. private placement market can be prepaid in whole or in part at any time subject to the payment of a prepayment penalty as provided for in the Note Purchase Agreement.

On April 20, 2021, the Company fully repaid its $400 million unsecured two-year term loan which was due on April 6, 2022. In June 2021, the Company amended its unsecured term loan of $300 million to extend the maturity date from April 2025 to June 2026.

On March 25, 2022, the Company amended and extended its unsecured revolving long-term bank credit facility of $1 billion to March 2027. As part of the amendment, LIBOR references were replaced with Term Secured Overnight Financing Rate (‘‘Term SOFR’’) and the revolving facility includes a sustainability-linked loan ("SLL") structure, whereby its applicable margins are adjusted upon achievement of certain sustainability targets, commencing in 2023. Revolving facility advances made prior to these amendments continue to apply LIBOR rates until the end of their term.

On March 25, 2022, the Company amended its $300 million term loan to replace LIBOR references by Term SOFR references.


QUARTERLY REPORT - Q3 2022 42


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
6. LONG-TERM DEBT (continued):

On June 30, 2022, the Company amended its notes purchase agreement to include LIBOR fallback provisions to replace LIBOR with adjusted term SOFR, adjusted daily simple SOFR or any relevant alternate rate selected by the note holders and the Company upon a benchmark transition event or early opt-in election.

The Company applied the IFRS 9 interest rate benchmark reform practical expedient for amendments required by the interest rate reform to the revolving-long term bank credit facility, term loan and related interest rate swap agreements.

The Company was in compliance with all financial covenants at October 2, 2022 and expects to maintain compliance with its covenants over the next twelve months, based on its current expectations and forecasts.


7. RESTRUCTURING AND ACQUISITION-RELATED (RECOVERY) COSTS:
Three months endedNine months ended
October 2,
2022		October 3,
2021		October 2,
2022		October 3,
2021
Employee termination and benefit costs$— $40 $584 $251 
Exit, relocation and other costs367 509 1,170 3,195 
Net (gain) loss on disposal, write-downs, and accelerated depreciation of property, plant and equipment, right-of-use assets and computer software related to exit activities(5,004)265 (7,696)448 
Acquisition-related transaction costs— 150 105 150 
$(4,637)$964 $(5,837)$4,044 

Restructuring and acquisition-related recovery for the nine months ended October 2, 2022 mainly related to a gain of $6.0 million on business dispositions (note 8(f)), and a gain of $3.4 million on the sale of a former manufacturing facility in Mexico, partly offset by $2.1 million in accelerated depreciation of right-of-use assets, $0.6 million in employee termination and benefit costs related to the closure of a distribution center in the U.S., as well $0.8 million related to the completion of previously initiated restructuring activities.

Restructuring and acquisition-related costs for the nine months ended October 3, 2021 mainly related to the completion of previously initiated restructuring activities.

QUARTERLY REPORT - Q3 2022 43


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

8. OTHER INFORMATION:
(a) Depreciation and amortization:
Three months endedNine months ended
October 2,
2022		October 3,
2021		October 2,
2022		October 3,
2021
Depreciation of property, plant and equipment$26,000 $23,137 $77,345 $69,091 
Depreciation of right-of-use assets3,434 3,442 11,594 10,594 
Adjustment for the variation of depreciation included in inventories at the beginning and end of the period
(3,100)3,276 (6,531)12,393 
Amortization of intangible assets, excluding computer software
3,444 3,132 10,331 9,687 
Amortization of computer software1,367 1,272 4,150 3,988 
Depreciation and amortization included in net earnings$31,145 $34,259 $96,889 $105,753 

Included in property, plant and equipment as at October 2, 2022 is $119.6 million (January 2, 2022 - $76.7 million) of buildings and equipment not yet available for use in operations. Included in intangible assets as at October 2, 2022 is $3.7 million (January 2, 2022 - $3.6 million) of software not yet available for use in operations. Depreciation and amortization on these assets commence when the assets are available for use.

Effective January 3, 2022, the Company revised the estimated useful life of certain Textile & Sewing manufacturing equipment based on a re-assessment of their expected use to the Company and recent experience of their economic life. These assets, which were previously being depreciated on a straight-line basis over 10 years, will be depreciated on a straight-line basis over 15 years. The change in estimate has been made on a prospective basis. For the year ending January 1, 2023, the change in estimate is expected to result in a reduction of depreciation included in net earnings of approximately $5 million.

As at October 2, 2022, the Company has approximately $230 million in commitments to purchase property and equipment, mainly related to manufacturing capacity expansion projects.

(b) Financial expenses, net:
Three months endedNine months ended
October 2,
2022		October 3,
2021		October 2,
2022		October 3,
2021
Interest expense on financial liabilities recorded at amortized cost(1)
$7,116 $3,274 $15,860 $13,031 
Bank and other financial charges2,973 1,689 6,907 6,992 
Interest accretion on discounted lease obligations
728 633 2,285 2,053 
Interest accretion on discounted provisions53 35 155 105 
Foreign exchange (gain) loss(1,559)(315)(1,532)485 
$9,311 $5,316 $23,675 $22,666 
(1) Net of capitalized borrowing costs of $0.7 million (2021 - $0.4 million) and $1.4 million (2021 - $1.3 million), respectively, for the three and nine months ended October 2, 2022.

QUARTERLY REPORT - Q3 2022 44


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

8. OTHER INFORMATION (continued):
(c) Related party transaction:
The Company incurred expenses for aircraft usage of $0.1 million (2021 - $0.3 million) and $1.6 million (2021 - $1.1 million) respectively, for the three and nine months ended October 2, 2022, with a company controlled by the President and Chief Executive Officer of the Company. The payments made are in accordance with the terms of the agreement established and agreed to by the related parties. As at October 2, 2022, the amount in accounts payable and accrued liabilities related to the airplane usage was $0.1 million (January 2, 2022 - $0.3 million).

(d) Lease obligations:
The Company’s leases are primarily for manufacturing, sales, distribution, and administrative facilities.

The following table presents lease obligations recorded in the statement of financial position:
October 2,
2022		January 2,
2022
Current$13,442 $15,290 
Non-current79,460 93,812 
$92,902 $109,102 

The following table presents the future minimum lease payments under non-cancellable leases (including short-term leases) as at October 2, 2022:
October 2,
2022
Less than one year$18,930 
One to five years52,018
More than five years45,722 
$116,670 

For the three and nine months ended October 2, 2022, the total cash outflow for recognized lease obligations (including interest) was $4.8 million and $15.4 million (2021 - $4.1 million and $14.5 million), of which $4.0 million and $13.1 million (2021 - $3.5 million and $12.5 million), respectively, was included as part of cash outflows used in financing activities.

QUARTERLY REPORT - Q3 2022 45


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

8. OTHER INFORMATION (continued):

(e) Cost of sales:
Included in cost of sales for the three and nine months ended October 2, 2022 are the following items:
•Included in cost of sales was an expense of $5.0 and $10.4 million, respectively, related to the write-down of inventory to net realizable value.

•Net insurance gains of nil and $0.3 million, respectively, related to the two hurricanes which occurred in Central America in November 2020. The insurance gains primarily relate to accrued insurance recoveries at replacement cost value for damaged equipment in excess of the write-off of the net book value of property plant and equipment.

Since November 2020, the Company has recognized $218.9 million of accrued insurance recoveries, of which $200.0 million has been received as an advance ($50.0 million in December 2020, $50.0 million in March 2021, $50.0 million in June 2021 and $50.0 million in September 2021). As at October 2, 2022, $18.9 million of insurance recoveries receivable are recorded in prepaid expenses, deposits and other current assets in the consolidated statement of financial position.

The Company recognizes insurance recoveries for items that it has an unconditional contractual right to receive. The Company expects to recognize additional insurance recoveries as the insurance claim process progresses.

Included in cost of sales for the three and nine months ended October 3, 2021 are the following items:
•A reduction of cost of sales related to pandemic government assistance for users of U.S. cotton of $18.3 million, for the nine months ended October 3, 2021.

•Net insurance gains of $29.9 million and $48.9 million, for the three and nine months ended October 3, 2021, respectively, related to the two hurricanes which occurred in Central America in November 2020. The net insurance gains reflected costs of $11.0 million and $50.6 million, for the three and nine months ended October 3, 2021, respectively, (mainly attributable to equipment repairs, salary and benefits continuation for idle employees, and other costs and charges), which were more than offset by related accrued insurance recoveries of $40.9 million and $99.5 million for the three and nine months ended October 3, 2021, respectively. The insurance gains primarily relate to accrued insurance recoveries at replacement cost value for damaged equipment in excess of the write-off of the net book value of property plant and equipment.

•For the nine months ended October 3, 2021, charges of $1.2 million related to the Company’s strategic initiatives to significantly reduce its product line stock-keeping unit ("SKU") counts.

(f) Business dispositions:
On August 1, 2022 the Company sold a yarn spinning facility located in the U.S., which was the smallest of the four facilities that the Company acquired on December 10, 2021 as part of the Frontier Yarns acquisition (the Company acquired 100% of the equity interest of Phoenix Sanford, LLC, the parent company of Frontier Yarns). The sale included the disposition of inventory, equipment, goodwill and the transfer of a leasehold interest and related lease liability. The proceeds of disposition of $29.4 million exceeded the carrying value of net assets sold of $23.3 million (including $13.9 million of goodwill), resulting in a pre-tax gain on disposal of $6.0 million ($1.0 million after tax). $1.5 million of the sale proceeds is being held in escrow, subject to the finalization of certain post-closing matters. The pre-tax gain of $6.0 million is included as a recovery in restructuring and acquisition-related costs.

QUARTERLY REPORT - Q3 2022 46


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

9. FAIR VALUE MEASUREMENT:
Financial instruments – carrying amounts and fair values:
The carrying amounts and fair values of financial assets and liabilities included in the unaudited condensed interim consolidated statements of financial position are as follows:
October 2,
2022		January 2,
2022
Financial assets
Amortized cost:
Cash and cash equivalents$69,249 $179,246 
Trade accounts receivable431,476 329,967 
Financial assets included in prepaid expenses, deposits and other current assets
61,066 69,995 
Long-term non-trade receivables included in other non-current assets188 390 
Fair value through other comprehensive income:
Derivative financial assets included in prepaid expenses, deposits and other current assets
30,068 62,758 
Financial liabilities
Amortized cost:
Accounts payable and accrued liabilities(1)
490,579 436,073 
Long-term debt - bearing interest at variable rates720,000 400,000 
Long-term debt - bearing interest at fixed rates(2)
200,000 200,000 
Fair value through other comprehensive income:
Derivative financial liabilities included in accounts payable and accrued liabilities
12,453 4,328 
(1) Accounts payable and accrued liabilities include $26.0 million (January 2, 2022 - $18.1 million) under supply-chain financing arrangements (reverse factoring) with a financial institution, whereby receivables due from the Company to certain suppliers can be collected by the suppliers from a financial institution before their original due date. These balances are classified as accounts payable and accrued liabilities and the related payments as cash flows from operating activities, given the principal business purpose of the arrangement is to provide funding to the supplier and not the Company, the arrangement does not significantly extend the payment terms beyond the normal terms agreed with other suppliers, and no additional deferral or special guarantees to secure the payments are included in the arrangement. Accounts payable and accrued liabilities also include balances payable of $21.8 million (January 2, 2022 - $48.8 million) resulting mainly from a one-week timing difference between the collection of sold receivables and the weekly remittance to our bank counterparty under our receivables purchase agreement that is disclosed in note 4 to these consolidated financial statements.
(2) The fair value of the long-term debt bearing interest at fixed rates was $195.4 million as at October 2, 2022 (January 2, 2022 - $212.2 million).

Short-term financial assets and liabilities
The Company has determined that the fair value of its short-term financial assets and liabilities approximates their respective carrying amounts as at the reporting dates due to the short-term maturities of these instruments, as they bear variable interest-rates, or because the terms and conditions are comparable to current market terms and conditions for similar items.

Non-current assets and long-term debt bearing interest at variable rates
The fair values of the long-term non-trade receivables included in other non-current assets and the Company’s long-term debt bearing interest at variable rates also approximate their respective carrying amounts because the interest rates applied to measure their carrying amounts approximate current market interest rates.


QUARTERLY REPORT - Q3 2022 47


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
9. FAIR VALUE MEASUREMENT (continued):

Long-term debt bearing interest at fixed rates
The fair value of the long-term debt bearing interest at fixed rates is determined using the discounted future cash flows method and at discount rates based on yield to maturities for similar issuances. The fair value of the long-term debt bearing interest at fixed rates was measured using Level 2 inputs in the fair value hierarchy. In determining the fair value of the long-term debt bearing interest at fixed rates, the Company takes into account its own credit risk and the credit risk of the counterparties.

Derivatives
Derivative financial instruments are designated as effective hedging instruments and consist of foreign exchange and commodity forward, option, and swap contracts, as well as floating-to-fixed interest rate swaps to fix the variable interest rates on a designated portion of borrowings under the term loan and unsecured notes. The fair value of the forward contracts is measured using a generally accepted valuation technique which is the discounted value of the difference between the contract’s value at maturity based on the rate set out in the contract and the contract’s value at maturity based on the rate that the counterparty would use if it were to renegotiate the same contract terms at the measurement date under current conditions. The fair value of the option contracts is measured using option pricing models that utilize a variety of inputs that are a combination of quoted prices and market-corroborated inputs, including volatility estimates and option adjusted credit spreads. The fair value of the interest rate swaps is determined based on market data, by measuring the difference between the fixed contracted rate and the forward curve for the applicable floating interest rates.

The Company also has a total return swap (“TRS”) outstanding that is intended to reduce the variability of net earnings associated with deferred share units, which are settled in cash. The TRS is not designated as a hedging instrument and, therefore, the fair value adjustment at the end of each reporting period is recognized in selling, general and administrative expenses. The fair value of the TRS is measured by reference to the market price of the Company’s common shares, at each reporting date. The TRS has a one-year term, may be extended annually, and the contract allows for early termination at the option of the Company. As at October 2, 2022, the notional amount of TRS outstanding was 324,855 shares.

Derivative financial instruments were measured using Level 2 inputs in the fair value hierarchy. In determining the fair value of derivative financial instruments the Company takes into account its own credit risk and the credit risk of the counterparties.

QUARTERLY REPORT - Q3 2022 48


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

10. OTHER COMPREHENSIVE (LOSS) INCOME (“OCI”):
Three months endedNine months ended
October 2,
2022		October 3,
2021		October 2,
2022		October 3,
2021
Net gain (loss) on derivatives designated as cash flow hedges:
Foreign currency risk$5,281 $3,062 $14,524 $1,961 
Commodity price risk(12,267)37,867 42,359 49,616 
Interest rate risk7,068 1,120 19,473 4,549 
Income taxes(53)(31)(145)(20)
Amounts reclassified from OCI to inventory, related to commodity price risk
(35,110)884 (100,280)(6,141)
Amounts reclassified from OCI to net earnings, related to foreign currency risk, commodity price risk, and interest rate risk, and included in:
Net sales(3,532)522 (8,358)4,281 
Cost of sales43 — 37 — 
Selling, general and administrative expenses
104 (432)63 (1,449)
Financial expenses, net(2,028)(923)(4,458)743 
Income taxes53 9 124 (37)
Other comprehensive (loss) income $(40,441)$42,078 $(36,661)$53,503 

The change in the time value element of option and swap contracts designated as cash flow hedges to reduce the exposure in movements of commodity prices was not significant for the three and nine months ended October 2, 2022 and for the three and nine months ended October 3, 2021. The change in the forward element of derivatives designated as cash flow hedges to reduce foreign currency risk was not significant for the three and nine months ended October 2, 2022 and for the three and nine months ended October 3, 2021. No ineffectiveness has been recognized in net earnings for the three and nine months ended October 2, 2022 and for the three and nine months ended October 3, 2021.

As at October 2, 2022, accumulated other comprehensive income of $28.1 million consisted of net deferred gains on commodity forward, option, and swap contracts of $6.9 million, net deferred gains on interest rate swap contracts of $16.9 million, and net deferred gains on forward foreign exchange contracts of $4.3 million. Approximately $19.6 million of net gains presented in accumulated other comprehensive income are expected to be reclassified to inventory or net earnings within the next twelve months.


QUARTERLY REPORT - Q3 2022 49


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

11. EARNINGS PER SHARE:
Reconciliation between basic and diluted earnings per share is as follows:
Three months endedNine months ended
October 2,
2022		October 3,
2021		October 2,
2022		October 3,
2021
Net earnings - basic and diluted$153,036 $188,304 $457,640 $433,287 
Basic earnings per share:
Basic weighted average number of common shares outstanding
181,980 197,334 185,610 198,072 
Basic earnings per share$0.84 $0.95 $2.47 $2.19 
Diluted earnings per share:
Basic weighted average number of common shares outstanding
181,980 197,334 185,610 198,072 
Plus dilutive impact of stock options, Treasury RSUs and common shares held in trust
259 725 490 469 
Diluted weighted average number of common shares outstanding
182,239 198,059 186,100 198,541 
Diluted earnings per share$0.84 $0.95 $2.46 $2.18 

Excluded from the above calculation for the three months ended October 2, 2022 are 1,132,737 stock options (2021 - nil) and 25,614 Treasury RSUs (2021 - nil) which were deemed to be anti-dilutive. Excluded from the above calculation for the nine months ended October 2, 2022 are nil stock options (2021 - 850,000) and 25,614 Treasury RSUs (2021 - 5,469) which were deemed to be anti-dilutive.


12. SUPPLEMENTAL CASH FLOW DISCLOSURE:
(a) Adjustments to reconcile net earnings to cash flows from (used in) operating activities - other items:
Three months endedNine months ended
October 2,
2022		October 3,
2021		October 2,
2022		October 3,
2021
Deferred income taxes$10,180 $2,224 $14,180 $5,793 
Unrealized net loss (gain) on foreign exchange and financial derivatives13 1,478 (834)(3,698)
Other non-current assets438 460 1,468 1,286 
Other non-current liabilities2,210 1,406 2,137 343 
$12,841 $5,568 $16,951 $3,724 
QUARTERLY REPORT - Q3 2022 50


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

12. SUPPLEMENTAL CASH FLOW DISCLOSURE (continued):
(b) Variations in non-cash transactions:
Three months endedNine months ended
October 2,
2022		October 3,
2021		October 2,
2022		October 3,
2021
Shares repurchased for cancellation included in accounts payable and accrued liabilities
$1,475 $— $(970)$— 
Net additions to property, plant and equipment and intangible assets included in accounts payable and accrued liabilities(13,288)(1,048)(2,377)3,471 
Proceeds on disposal of property, plant and equipment and computer software included in other current assets447 — 392 — 
(Lease modifications) additions to right-of-use assets included in lease obligations(8,677)6,056 (1,247)5,892 
Non-cash ascribed value credited to share capital from shares issued or distributed pursuant to vesting of restricted share units and exercise of stock options
— — 4,582 2,617 
Deferred compensation credited to contributed surplus— — (2,110)(2,197)
Non-cash ascribed value credited to contributed surplus for dividends attributed to restricted share units
385 325 1,127 640 

(c) Changes in non-cash working capital balances:
Three months endedNine months ended
October 2,
2022		October 3,
2021		October 2,
2022		October 3,
2021
Trade accounts receivable$25,997 $(32,509)$(107,157)$(179,454)
Income taxes(2,075)4,349 (4,516)10,020 
Inventories(141,318)(8,002)(334,553)(9,822)
Prepaid expenses, deposits and other current assets7,839 (5,510)17,264 (9,952)
Accounts payable and accrued liabilities5,171 68,301 63,945 133,623 
$(104,386)$26,629 $(365,017)$(55,585)

QUARTERLY REPORT - Q3 2022 51


image3.jpg
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

13. CONTINGENT LIABILITIES:
Claims and litigation
The Company is a party to claims and litigation arising in the normal course of operations. The Company does not expect the resolution of these matters to have a material adverse effect on the financial position or results of operations of the Company.

14. DISAGGREGATION OF REVENUE:
Net sales by major product group were as follows:
Three months endedNine months ended
October 2,
2022		October 3,
2021		October 2,
2022		October 3,
2021
Activewear$742,012 $655,831 $2,167,085 $1,737,553 
Hosiery and underwear107,996 145,750 353,375 400,766 
$850,008 $801,581 $2,520,460 $2,138,319 

Net sales were derived from customers located in the following geographic areas:
Three months endedNine months ended
October 2,
2022		October 3,
2021		October 2,
2022		October 3,
2021
United States$742,291 $685,904 $2,220,185 $1,833,979 
Canada38,160 36,113 99,798 83,856 
International69,557 79,564 200,477 220,484 
$850,008 $801,581 $2,520,460 $2,138,319 

QUARTERLY REPORT - Q3 2022 52